Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer

Description

The purpose of this research is to assess the safety and evaluate the potential of the Multispectral Optoacoustic Tomography (MSOT) device to more precisely identify and assess the neck lymph nodes which might be affected in patients with metastatic head and neck squamous cell carcinomas.

Conditions

Head and Neck Squamous Cell Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this research is to assess the safety and evaluate the potential of the Multispectral Optoacoustic Tomography (MSOT) device to more precisely identify and assess the neck lymph nodes which might be affected in patients with metastatic head and neck squamous cell carcinomas.

Multispectral Optoacoustic Tomography for the Detection of Extranodal Extension and Radiation Induced Fibrosis in Head and Neck Squamous Cell Cancer

Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer

Condition
Head and Neck Squamous Cell Carcinoma
Intervention / Treatment

-

Contacts and Locations

Oklahoma City

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States, 73104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Clinically confirmed node positive head and neck squamous cell cancer
  • * Written informed consent signed and dated by the patient prior to the performance of the MSOT
  • * At least 18 years-of-age at the time of signature of the informed consent form (ICF)
  • * Patients planned for curative intent therapy
  • * Patient available for the study duration
  • * Patients of childbearing potential must have a negative pregnancy test prior to the study entry.
  • * Patients of childbearing potential must use an effective form of contraceptive as per the protocol.
  • * History of previous head and neck radiotherapy
  • * Intent of treatment palliative
  • * Women who are pregnant
  • * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety of efficacy assessment of the investigational regimen should be included.
  • * Psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol and/or follow-up procedures outlined in the protocol.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Oklahoma,

Christina Henson, MD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

2027-08